The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s External Pacemakers Global Market Report 2024, the external pacemakers market is expected to show significant growth in the forecast period.

• Strong Market Growth: The external pacemakers market has seen significant growth, expanding from $1.44 billion in 2023 to an anticipated $1.52 billion in 2024. This represents a compound annual growth rate (CAGR) of 5.6%.
• Key Drivers:
  • Shift towards less invasive surgical techniques.
  • Increased demand for minimally invasive structural heart devices.
  • Ongoing training and education programs for healthcare professionals.
  • Rising healthcare expenditure.
  • Growing patient preference for non-surgical or minimally invasive treatment options.

Forecasted Expansion: The Path Ahead

• Future Growth Expectations: The external pacemakers market is expected to grow from $1.52 billion in 2024 to $1.90 billion by 2028, at a CAGR of 5.8%.
• Growth Catalysts:
  • Aging population and growing awareness about heart health.
  • Implementation of screening programs.
  • Favorable reimbursement policies for structural heart procedures.
  • Timely regulatory approvals for new structural heart devices.
• Major Trends:
  • Increasing adoption of transcatheter valve replacement.
  • Development of innovative devices with advanced materials.
  • Emphasis on personalized treatment approaches.
  • Integration of remote monitoring and telehealth solutions.

View More On The External Pacemakers Market Report 2024 – https://www.thebusinessresearchcompany.com/report/external-pacemakers-global-market-report

Addressing Cardiovascular Disease: The Role of External Pacemakers

• Cardiovascular Disease Burden: The rising incidence of cardiovascular diseases (CVD) is a significant driver of the external pacemaker market.
• Contributing Factors:
  • Sedentary lifestyles and poor dietary habits.
  • Increasing rates of obesity, smoking, and high blood pressure.
  • Stress and other health-related issues.
• Market Impact: The growing use of external pacemakers to regulate abnormal heart rhythms and improve cardiac function is critical in addressing the increasing prevalence of CVD. For example, projections by the World Heart Federation suggest that CVD deaths could rise from 18.9 million in 2020 to over 22.2 million by 2030, escalating further to 32.3 million by 2050.

Innovation in External Pacemakers: Leading the Way Forward

• Innovative Devices: Leading companies in the external pacemaker market are focusing on developing next-generation products to enhance patient outcomes.
• Miniaturized Pacemakers:
  • Product Example: Medtronic Plc’s Micra AV2 and Micra VR2, which received FDA approval in May 2023, represent significant advancements in pacemaker technology.
  • Key Features:
    • Up to 40% more battery life than previous models, with a median battery life ranging from 16 to 17 years.
    • Advanced algorithms for automatic AV synchrony programming.
    • Higher tracking capability for active patients.
    • Smaller size and leadless design reduce complications and improve patient experience.

Market Segmentation: A Detailed Overview

• Product Segmentation:
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
• Application Segmentation:
  • Bradycardia
  • Acute Myocardial Infarction
• End-User Segmentation:
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users

Regional Insights: Key Markets

• North America: Dominated the external pacemakers market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period, driven by increasing healthcare investments and growing awareness of cardiovascular health.

Request A Sample Of The Global External Pacemakers Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15807&type=smp